Pacer Advisors Inc. reduced its position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 73.9% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 101,340 shares of the company’s stock after selling 286,738 shares during the period. Pacer Advisors Inc.’s holdings in Astera Labs were worth $11,107,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in ALAB. Reflection Asset Management bought a new position in Astera Labs in the fourth quarter valued at about $25,000. Smartleaf Asset Management LLC increased its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in Astera Labs during the 4th quarter worth about $33,000. Whipplewood Advisors LLC raised its holdings in Astera Labs by 15,950.0% during the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after purchasing an additional 319 shares during the last quarter. Finally, Assetmark Inc. lifted its position in Astera Labs by 78.9% during the 4th quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after purchasing an additional 101 shares during the period. Institutional investors own 60.47% of the company’s stock.
Insider Activity
In related news, Director Manuel Alba sold 136,974 shares of Astera Labs stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the sale, the director owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of the company’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $200.16, for a total value of $28,012,592.16. Following the sale, the chief executive officer owned 3,929,183 shares in the company, valued at $786,465,269.28. The trade was a 3.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,676,845 shares of company stock worth $444,928,806 in the last quarter. Corporate insiders own 10.40% of the company’s stock.
Astera Labs Stock Up 12.7%
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same period last year, the business posted $0.44 earnings per share. The firm’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts expect that Astera Labs, Inc. will post 1.86 earnings per share for the current year.
Wall Street Analysts Forecast Growth
ALAB has been the subject of several analyst reports. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Citigroup restated a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Susquehanna raised their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. TD Cowen upped their target price on shares of Astera Labs from $225.00 to $425.00 and gave the company a “hold” rating in a research report on Monday, July 13th. Finally, Needham & Company LLC lifted their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Thirteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $289.00.
Check Out Our Latest Report on ALAB
Key Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Q2 earnings and revenue beat expectations. Astera Labs reported adjusted earnings of $0.80 per share, above the $0.69 consensus estimate and up from $0.44 a year earlier. Revenue reached a record $392.4 million, exceeding the $360.85 million estimate and increasing 104.5% year over year. Astera Labs Beats Q2 Earnings and Revenue Estimates
- Positive Sentiment: Q3 guidance was well above analyst forecasts. Management projected earnings of $1.16-$1.21 per share and revenue of $540 million-$560 million, compared with consensus estimates of $0.73 per share and $410.3 million in revenue. The outlook implies another sharp acceleration in growth. Astera Labs Reports Second Quarter 2026 Financial Results
- Positive Sentiment: New product ramp is expected to drive the acceleration. Astera Labs said Q3 growth will be supported by production ramp-up of its Scorpio X-Series 320-lane fabric switch, alongside diversified demand across AI fabrics and signal-conditioning products. Astera Labs Stock Shoots Higher After Q2 Earnings
- Neutral Sentiment: Investor expectations were already elevated. Recent coverage highlighted optimism surrounding Astera Labs’ Amazon partnership and AI infrastructure exposure, helping the stock advance ahead of earnings. Its high valuation and volatility mean additional upside may depend on continued results that exceed expectations. Astera Labs Benefits From Amazon Partnership
- Negative Sentiment: One analyst target remains below the current market level. A previously reported price-target increase to $275 suggests some valuation caution, although that target predates the latest earnings report and guidance. Astera Labs Price Target Raised to $275
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
